Prostate cancer trial aims to reduce radiation treatments
VCU Massey Cancer Center has opened a Phase I clinical trial testing an innovative radiation therapy for patients with early stage prostate cancer that has the potential to drastically reduce treatment time. In comparison to the standard schedule of eight weeks of daily external beam radiation therapy, the new technique requires just four treatments, administered twice in the first week and twice in the fourth week.
MicroRNA study funded by National Institute of Justice
A collaborative team of cancer and forensic science researchers at Virginia Commonwealth University (VCU) and VCU Massey Cancer Center were awarded a two-year, $310,000 grant from the Office of Justice Programs, housed within the National Institute of Justice (NIJ), to study microRNAs. MicroRNAs are a recently discovered class of RNAs that play key roles in the regulation of gene expression.
New drug combination therapy developed to treat leukemia
A new, pre-clinical study by researchers at Virginia Commonwealth University Massey Cancer Center suggests that a novel drug combination could lead to profound leukemia cell death by disrupting the function of two major pro-survival proteins. The effectiveness of the therapy lies in its ability to target a pro-survival cell signaling pathway known as PI3K/AKT/mTOR, upon which the leukemia cells have become dependent.
Tobacco Commission awards research funding to Massey
For the third time, the Tobacco Indemnification and Community Revitalization Commission (TICRC, a.k.a.Tobacco Commission) awarded funding to VCU Massey Cancer Center to support cancer research in the tobacco-dependant counties of Southside and Southwest Virginia. Nearly $600,000 was given to support research projects that involve a cohesive mission of cancer prevention and control.
VCU Massey physicians cited as Top Docs in Richmond Magazine
VCU Massey Cancer Center physicians were recognized as “Top Docs” in Richmond Magazine’s April 2013 issue. Topping the list were 34 doctors from varied specialties who provide oncology-related care to Massey's patients. The selections were the result of a survey that asked Richmond-area physicians who they would recommend in a range of specialties. The following full-time Massey physicians were listed as top performers in the categories noted: